Pfizer hits pause on deals amid US tax reform uncertainty https://t.co/cm4OcvcQPs via @FT
— The Propell Group (@ThePropellGroup) August 2, 2017
#healthtech
Pfizer hits pause on deals amid US tax reform uncertainty https://t.co/cm4OcvcQPs via @FT
— The Propell Group (@ThePropellGroup) August 2, 2017
#healthtech